Effect of nebulized dexmedetomidine on gag reflex suppression and sedation quality in pediatric patients undergoing

Esra Turunc1, Yasemin Burcu Ustun2, Sezgin Bilgin2

  • 1Department of Anesthesiology and Reanimation, Faculty of Medicine, Ondokuz Mayis University, Kurupelit, Samsun, TR55139, Turkey. esra.kiymaz.ek@gmail.com.

BMC Anesthesiology
|May 3, 2025
PubMed

Insights

Nebulized dexmedetomidine significantly reduces gag and cough reflexes in pediatric endoscopy patients. This safe and effective premedication improves patient comfort and procedural success.

Area of Science:

  • Pediatric Gastroenterology
  • Anesthesiology
  • Pharmacology

Background:

  • Pediatric upper gastrointestinal (GI) endoscopy often necessitates sedation and analgesia.
  • The gag reflex presents a significant challenge during endoscopic probe placement in children.
  • Effective management of gag reflex is crucial for successful pediatric GI procedures.

Purpose of the Study:

  • To investigate the efficacy of nebulized dexmedetomidine as a premedication in pediatric patients undergoing upper GI endoscopy.
  • To assess the impact of nebulized dexmedetomidine on gag reflex severity during pediatric endoscopy.
  • To evaluate secondary outcomes including cough, anxiety, agitation, and endoscopist satisfaction.

Main Methods:

  • A single-center, prospective, randomized controlled trial was conducted involving pediatric patients aged 2-17 years.
  • Participants were randomized to receive either nebulized dexmedetomidine (2 µg/kg) or no premedication.
  • Gag reflex severity was the primary outcome; cough, anxiety, agitation, and satisfaction were secondary outcomes.

Main Results:

  • Nebulized dexmedetomidine significantly reduced gag reflex incidence (88.3% vs. 30%, p<0.001) and coughing (95% vs. 55%, p<0.001).
  • The dexmedetomidine group showed significantly lower separation anxiety scores (p<0.005).
  • Reduced need for additional anesthetics and higher endoscopist satisfaction were observed, with no significant increase in complications.

Conclusions:

  • Nebulized dexmedetomidine is a safe and effective premedication for pediatric endoscopy.
  • It significantly mitigates gag and cough reflexes, enhancing patient comfort and procedural safety.
  • This approach improves endoscopist satisfaction and reduces anesthetic requirements in pediatric GI procedures.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
91
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
158
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
336
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
448
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
327
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
299